Mechanism of action of a repressor of dioxin-dependent induction of Cyp1a1 gene transcription.
A dominant mutant of Hepa-1 cells, c31, expresses a repressor that prevents 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-dependent stimulation of Cyp1a1 transcription. The repressor acts via the xenobiotic-responsive elements (XREs), which are the DNA-binding sites for the aryl hydrocarbon (Ah) receptor-TCDD complex during transcriptional activation of the gene. High-salt nuclear extracts prepared from c31 cells grown with TCDD contained normal levels of the Ah receptor which bound the XRE with normal affinity, as judged by in vitro gel mobility shift assays. Furthermore, extracts prepared from these cells, grown either with or without TCDD, contained no novel XRE-binding proteins compared with extracts from wild-type Hepa-1 cells. However, in vivo genomic footprinting demonstrated that TCDD treatment leads to binding of the Ah receptor to the XREs in Hepa-1 but not mutant cells. This finding suggests that the repressor associates with the Ah receptor to prevent its binding to the XREs and that high-salt treatment either causes dissociation of the receptor/repressor complex or fails to extract the repressor from nuclei. The results underscore the importance of using both in vivo and in vitro assays for analyzing DNA-protein interactions.
Watson
A J
AJ
Laboratory of Biomedical and Environmental Sciences, School of Public Health, University of California, Los Angeles 90024-1786.
Weir-Brown
K I
KI
Bannister
R M
RM
Chu
F F
FF
Reisz-Porszasz
S
S
Fujii-Kuriyama
Y
Y
Sogawa
K
K
Hankinson
O
O
D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D002460:Cell Line; D002678:Chimera; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism; D004273:DNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D004790:Enzyme Induction; D004794:Enzyme Repression; D005799:Genes, Dominant; D008114:Liver Neoplasms, Experimental; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D000072317:Polychlorinated Dibenzodioxins / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D018336:Receptors, Aryl Hydrocarbon; D011955:Receptors, Drug / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D012097:Repressor Proteins / Q000378:metabolism*; D015183:Restriction Mapping; D014158:Transcription, Genetic / Q000187:drug effects*; D014162:Transfection
D004273:DNA, Neoplasm; D000072317:Polychlorinated Dibenzodioxins; D018336:Receptors, Aryl Hydrocarbon; D011955:Receptors, Drug; D011993:Recombinant Fusion Proteins; D012097:Repressor Proteins; D003577:Cytochrome P-450 Enzyme System; D015500:Chloramphenicol O-Acetyltransferase